NOSKI CHARLES H 4
4 · Hewlett Packard Enterprise Co · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
HPE Director Charles H. Noski Exercises 14,499 Shares
What Happened Charles H. Noski, a member of Hewlett Packard Enterprise's Board of Directors, converted/exercised derivative securities into 14,499.052 shares on 2026-04-01. The filing records an acquisition price of $23.98 per share, totaling approximately $347,687. Noski elected to defer receipt of the common stock until he leaves the board (footnote F1), so this was not an open-market sale.
Key Details
- Transaction date: 2026-04-01; Form 4 filed 2026-04-03 (appears timely).
- Type: M = exercise/conversion of derivative securities (conversion of RSUs/dividend equivalents).
- Shares reported acquired: 14,499.052 at $23.98; reported value ≈ $347,687.
- A corresponding “disposed” line reflects the conversion of the derivative instrument, not an open-market sale of shares.
- Footnotes: F1 — Noski elected to defer receipt of common stock until termination of board service. F2–F4 — the reported amount includes vested RSU dividend-equivalent credits (several small allocations on 7/17/25, 10/17/25, and 1/16/26) and reflects previously granted RSUs that cliff vested at the 2026 Annual Meeting.
- Shares owned after the transaction: not specified in the filing.
Context
- This transaction reflects conversion of restricted stock units/dividend equivalents into shares (derivative exercise/conversion). Because Noski deferred receipt, there was no immediate open‑market purchase or sale of stock and it does not signal an immediate liquidity event.
- For retail investors, conversions and awards are typically routine compensation-related events for directors; purchases are generally more informative as bullish signals than conversions or deferred awards.
Insider Transaction Report
Form 4
NOSKI CHARLES H
Director
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-04-01$23.98/sh+14,499.052$347,687→ 79,945.193 total(indirect: By Merrill Lynch) - Exercise/Conversion
Restricted Stock Units
[F3][F4]2026-04-01−14,499.052→ 0 total→ Common Stock (14,499.052 underlying)
Holdings
- 0
Common Stock
- 24,745(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.
- [F2]The number of shares in column 5 includes 374.1979 vested restricted stock unit ("RSU") dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 339.4834 vested RSU dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, and 398.5082 vested RSU dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F4]As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights.
Signature
Jonathan Sturz as Attorney-in-Fact for Charles H. Noski|2026-04-03